Breakthrough in Huntington’s Disease Treatment with Successful Gene Therapy Trials
TL;DR Summary
An experimental gene therapy called AMT-130 from Uniqure significantly slowed Huntington's disease progression by 75% over three years, potentially paving the way for the first genetic treatment approval for this neurodegenerative disorder.
- Experimental gene therapy for Huntington’s markedly slowed disease progression in key trial statnews.com
- Huntington's disease successfully treated for first time BBC
- A clever genetic technique may treat a horrible brain condition The Economist
- Huntington’s disease treated successfully for first time in UK gene therapy trial The Guardian
- UniQure ‘Exceeds Expectations’ in Much-Anticipated 3-Year Huntington’s Readout BioSpace
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 2 min read
Condensed
87%
251 → 32 words
Want the full story? Read the original article
Read on statnews.com